DNA methylation mediates the immunosuppressive tumour microenvironment in metastatic endometrial clear cell carcinoma
Authors:
Open Access
- 1 October 2025
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 120, 105954
Abstract
No abstract availableKeywords
Funding Information
- Qingdao Municipal Science and Technology Bureau (23-2-8-smjk-19-nsh)
- Shenzhen Science and Technology Innovation Program (GZL202309043419000025)
- National Natural Science Foundation of China
- Qingdao University
This publication has 64 references indexed in Scilit:
- methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profilesGenome Biology, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis AntigenClinical Cancer Research, 2009
- Management of women with clear cell endometrial cancerGynecologic Oncology, 2009
- Carcinoma of the Corpus UteriInternational Journal of Gynecology & Obstetrics, 2006
- Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach.Human Genetics, 2003
- Defective activation and survival of T cells lacking the Ets-1 transcription factorNature, 1995
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983